Institute for Clinical and Economic Review (ICER)

ICER Weekly View: ICER CEO on RHV Podcast, Medicare negotiated prices, & PBM alternatives emerge Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View December 5, 2025 From the desk of ICER Communications Goo

ICER #WeeklyView: ICER CEO on RHV Podcast, Medicare negotiated prices, & PBM alternatives emerge conta.cc/3Mfy4ZP

EP494: Six Tensions of Pharmaceutical Drug Pricing, With Sarah Emond | A Scrupulously Fair Assessment of What is Wrong and Right about American Healthcare - A Healthcare Industry Podcast Listen On Your Favorite App I was out drinking martinis with Cora Opsahl, director of 32BJ Health Fund , and Cora said, "Look, most plan sponsors' biggest...

ICER President and CEO Sarah K. Emond joined the @relentleshealth.bsky.social pod to discuss the tensions that exist in drug pricing and how paying for value can help fix them. Listen: cc-lnk.com/EP494.

The bonus episode talks about ICER's work and more: cc-lnk.com/EP494-BonusC....

This week ICER marks the 5-year anniversary of ICER Analytics™, our cloud-based platform that has revolutionized the ability of users to develop formularies, negotiate drug prices, and explore new ways to apply ICER’s evidence. Learn more at analytics.icer.org.

ICER Weekly View: ICER Analytics is 5, ICER interviewed on GLP-1 pricing, & health benefits costs to increase Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View November 21, 2025 From the desk of ICER Communications (P

ICER #WeeklyView: ICER Analytics is 5, ICER interviewed on GLP-1 pricing, & health benefits costs to increase conta.cc/4ieQnKC

ICER Weekly View: This holiday season, consider donating to ICER Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View November 14, 2025 From the desk of ICER Communications Go

ICER #WeeklyView: This holiday season, consider donating to ICER conta.cc/4oMsVXK

Institute for Clinical and Economic Review Releases Draft Scope on Vaccines for Covid-19: tinyurl.com/4enrmhsf

ICER Weekly View: Obesity public meeting, paying for value for obesity meds, & responses to ICER’s Launch Price and Access Report Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View November 7, 2025 From the desk of ICER Communications Goo

ICER #WeeklyView: Obesity public meeting, paying for value for obesity meds, & responses to ICER’s Launch Price and Access Report conta.cc/4nLPYAy

ICER Weekly View: NCFB and obesity Evidence Reports, Cigna ends rebates, & updated approval for biosimilars Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View October 31, 2025 From the desk of ICER Communications Hap

ICER #WeeklyView: NCFB and obesity Evidence Reports, Cigna ends rebates, & updated approval for biosimilars conta.cc/4oIRkg6

Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatment for Non-Cystic Fibrosis Bronchiectasis: tinyurl.com/4rmnz269

Institute for Clinical and Economic Review Publishes Evidence Report on Treatments for Obesity: tinyurl.com/3wbemnr9

2025 Launch Price and Access Report: Policy Implications

Today: Join ICER for a conversation around rising launch prices, and the implications for affordability and patient access. Register for the 2025 Launch Price and Access Report: Policy Implications webinar: tinyurl.com/3xukfka2

ICER Weekly View: Launch Price and Access Report and webinar, & assessments for narcolepsy and smoking cessation Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View October 24, 2025 From the desk of ICER Communications Goo

ICER #WeeklyView: Launch Price and Access Report and webinar, & assessments for narcolepsy and smoking cessation conta.cc/4nhUsP2

New Institute for Clinical and Economic Review Report Shows Significant Jump in Launch Prices, Exceeding Inflation and GDP Growth: tinyurl.com/46swvktj

Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatment for Smoking Cessation: tinyurl.com/3c9n6bkh

Institute for Clinical and Economic Review to Assess Treatment for Narcolepsy: tinyurl.com/2vw57seu

ICER Weekly View: Launch Price and Access Report webinar, On Point interview, & California PBM reforms Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View October 17, 2025 From the desk of ICER Communications Goo

ICER #WeeklyView: Launch Price and Access Report webinar, On Point interview, & California PBM reforms conta.cc/47fZHsJ

ICER Weekly View: HEMA Draft Report, ICER’s paper in Health Affairs Scholar, & the Colorado PDAP vote Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View October 10, 2025 From the desk of ICER Communications Goo

ICER #WeeklyView: HEMA Draft Report, ICER’s paper in Health Affairs Scholar, & the Colorado PDAP vote conta.cc/3KIpfXJ

Health Economics Methods Advisory Group Releases Draft Report: Assessing Treatment Benefits in HTA Decision-Making tinyurl.com/yc47dejv

How to make one line in the FDA Commissioner's new drug review program into a force for affordable access for patients Abstract. The FDA Commissioner's new National Priority Voucher program seeks to accelerate drug approvals for products meeting certain criteria. Interestin

How to make one line in the FDA Commissioner’s new drug review program into a force for affordable access for patients -- a new Health Affairs Scholar paper by ICER President and CEO Sarah Emond and Chief Scientific Officer Dan Ollendorf: tinyurl.com/32bexcd9

ICER Weekly View: Vaccines for COVID-19 to be assessed, Trump Administration’s drug pricing announcements, & ACA subsidies Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View October 3, 2025 From the desk of ICER Communications Good

ICER #WeeklyView: Vaccines for COVID-19 to be assessed, Trump Administration’s drug pricing announcements, & ACA subsidies conta.cc/4nCjZDy

Institute for Clinical and Economic Review to Assess Vaccines for COVID-19: tinyurl.com/2tfn5pme

ICER Weekly View: NCFB public meeting, GLP-1s lower costs, & pharma responses to new regulations Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View September 26, 2025 From the desk of ICER Communications G

ICER #WeeklyView: NCFB public meeting, GLP-1s lower costs, & pharma responses to new regulations conta.cc/3IIbHe7

ICER Weekly View: CMS report, GLP-1 cost-effectiveness, & soaring health care costs Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View September 19, 2025 From the desk of ICER Communications G

ICER #WeeklyView: CMS report, GLP-1 cost-effectiveness, & soaring health care costs conta.cc/4mjUh59

Institute for Clinical and Economic Review to Undertake Special Report on Crohn’s Disease and Ulcerative Colitis for CMS as Part of Public Comment Process on Medicare Drug Price Negotiations: tinyurl.com/4urn4xf7

ICER Weekly View: Obesity draft evidence report, NCFB evidence report, & a crackdown on pharma ads Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View September 12, 2025 From the desk of ICER Communications G

ICER #WeeklyView: Obesity draft evidence report, NCFB evidence report, & a crackdown on pharma ads conta.cc/46wGALw

Institute for Clinical and Economic Review Releases Draft Evidence Report on Treatments for Obesity: tinyurl.com/4zzsd7dw

Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Non-Cystic Fibrosis Bronchiectasis: tinyurl.com/39by2hs5

ICER Weekly View: SMA final evidence report, upcoming GLP-1 draft report & prescription drug reforms Email from Institute for Clinical and Economic Review ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View September 5, 2025 From the desk of ICER Communications Go

ICER #WeeklyView: SMA final evidence report, upcoming GLP-1 draft report & prescription drug reforms conta.cc/3V0BdOo

Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatments for Spinal Muscular Atrophy: tinyurl.com/mw453b9h

ICER Weekly View: A note from ICER’s CEO, rising employer health costs, & direct-to-consumer pricing Email from ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View August 22, 2025 From the desk of ICER Communications Good morning, everyone. Today we start things o

ICER #WeeklyView: A note from ICER’s CEO, rising employer health costs, & direct-to-consumer pricing conta.cc/4mV72nD